Skip to main content
. 2022 Jan 29;22:195. doi: 10.1186/s12889-022-12573-7

Table 3.

Unadjusted and adjusted models for HPV vaccine knowledge score and HPV vaccine initiation (n = 77)

HPV vaccine knowledge HPV vaccine initiation
Unadjusted B [95% CI] Adjusted B [95% CI] Unadjusted OR [95% CI] Adjusted OR [95% CI]
Parent Characteristics
 Nativity
  Non-U.S. Born −2.0 [−3.3, −0.7] −1.7 [− 3.1, − 0.4] 0.4 [0.1, 1.0] 0.3 [0.1, 0.9]
  U.S.-Born Reference Reference Reference Reference
 Age (years)
  30–40 Reference Reference
  41–50 1.3 [−0.4, 3.0] 0.8 [−1.3, 2.8]
  > 50 2.0 [0.1, 4.0] 1.5 [−0.7, 3.7]
 HPV Vaccine Knowledge 1.3 [1.1, 1.5] 1.3 [1.0, 1.7]
Adolescent Characteristics
 Age (years)
  11–12 0.2 [−1.6, 2.0] 0.5 [− 1.2, 2.2] 0.02 [0.003, 0.2] 0.01 [0.002, 0.2]
  13–15 −1.0 [−2.5, 0.5] −0.5 [−2.0, 1.0] 0.3 [0.1, 1.0] 0.4 [0.1, 1.6]
  16–18 Reference Reference Reference Reference
 Gender
  Male 0.3 [0.1, 0.9] 0.1 [0.0, 0.6]
  Female Reference
 Insurance Type
  Private Reference Reference
  Medicaid/CHIP −0.5 [−2.3, 1.3] −0.2 [−2.3, 2.0]
  Uninsured/Other −3.5 [−5.9, −1.1] −2.3 [−4.9, 0.4]
 Received Other Adolescent Vaccines
  Yes 3.8 [1.4, 10.1] 3.4 [0.9, 13.2]
  No Reference Reference

“–” indicates variable excluded from final model

HPV Human papillomavirus vaccine, OR Odds ratio, CI Confidence interval, CHIP Children’s Health Insurance Program, Tdap Tetanus, diphtheria, and acellular pertussis